Lexeo Therapeutics, Inc. Common Stock (LXEO) — QMA analysis
Sector: Healthcare · Market cap: $517M · Price: $3.23 · Data as of 2026-10-09
Kompozitní skóre 49/100 staví Lexeo Therapeutics, Inc. Common Stock do neutrálního pásma, čímž překonává 65 % z 22 788 sledovaných akcií. Nejvýraznější vrstvou je Analytici / transkripty, naopak nejslabší je Insider aktivita.
What 11 data layers say about LXEO
The composite fuses insiders, congressional trades, institutional 13F positions, fundamentals, momentum, seasonality and more into a single number.
| Layer | Score |
|---|---|
| Fundamentální hodnota (FVS) | 58/100 |
| Kvalita zisků (EQS) | 20/100 |
| Technický trend (TSS) | 43/100 |
| Relativní síla (RS) | 21/100 |
| Momentum (USS) | 36/100 |
| Insider aktivita (IAS) | 10/100 |
| Dark pool / velrybí toky (WHS) | 32/100 |
| Institucionální 13F (IFS) | 65/100 |
| Sentiment zpráv (NSS) | 51/100 |
| Analytici / transkripty (ATS) | 89/100 |
| Katalyzátory (XS) | 76/100 |
What does the QMA model currently show for Lexeo Therapeutics, Inc. Common Stock?
The composite score is an entry point, not a signal. What matters is layer confluence — whether they point the same direction.
U LXEO se vrstvy rozcházejí — některé signály jsou silné (Analytici / transkripty), jiné slabé (Insider aktivita). Rozpor mezi vrstvami je sám o sobě informací: model nedává jednoznačný obrázek. Skóre je vstup do vašeho rozhodování, ne doporučení.
LXEO insider & smart money activity
Za poslední období převažují u LXEO insiderské prodeje (7) nad nákupy (0). QMA to označuje jako negativní insider aktivitu — popis datové vrstvy, ne pokyn.
How LXEO compares
Similar stocks from the same sector:
Frequently asked questions
What is the composite score for LXEO stock?
48.5/100 (grade C) as of 2026-10-09, fusing 11 data layers. An analytical score, not advice.
Are insiders buying LXEO stock?
Over the recent period: 0 buys and 7 sells. Net insider activity: neutral (descriptive — not a trade instruction).
Where can I see live LXEO data?
Live LXEO data and all 17,000+ stocks unlock with a free QMA account — no card needed.
Explore more — for free
The LXEO score is just the start. Keep going free in the QMA magazine — analysis, tools and learning with no payment up front.
Want the full LXEO analysis with all layers and live data? Open LXEO detail →
Data from SEC and public markets. QMA is an analytical tool, not a registered investment advisor. No content on this page is investment advice or an instruction to buy or sell. Past performance does not guarantee future results.
⚠️ Important Notice: QMA is an analytical and educational tool, not investment advice. Scores, detections and ratings are descriptive, not buy/sell instructions. QMA is not a registered investment advisor (SEC / FINRA / MiFID II / ČNB). Consult a licensed financial advisor before any investment. Past performance does not guarantee future results; all investments carry the risk of capital loss.
Operator: Jaroslav Vojtášek · IČO: 48783447 · Place of business: U Jízdárny 577, 747 64 Velká Polom, Czech Republic · Register: Sole trader registered in the Czech Trade Licensing Register · E-mail: [email protected]